Innate Pharma SA Form 20-F: Annual report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2026-04-01: Form 20-F; Period of report 2025-12-31; Description 20-F; Document inpha-20251231.htm.
- 2025-04-30: Form 20-F; Period of report 2024-12-31; Description 20-F; Document inpha-20241231.htm.
- 2024-04-04: Form 20-F; Period of report 2023-12-31; Description 20-F; Document inpha-20231231.htm.
- 2023-04-06: Form 20-F; Period of report 2022-12-31; Description 20-F; Document inpha-20221231.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2026-04-01 | 20-F | 2025-12-31 | 20-F | inpha-20251231.htm |
| 2025-04-30 | 20-F | 2024-12-31 | 20-F | inpha-20241231.htm |
| 2024-04-04 | 20-F | 2023-12-31 | 20-F | inpha-20231231.htm |
| 2023-04-06 | 20-F | 2022-12-31 | 20-F | inpha-20221231.htm |
| 2022-04-04 | 20-F | 2021-12-31 | 20-F | inpha-20211231.htm |
| 2021-04-27 | 20-F | 2020-12-31 | 20-F | inpha-20201231.htm |
| 2020-04-24 | 20-F | 2019-12-31 | FORM 20-F | f20f_042420.htm |